BRPI0921057A2 - compostos derivados de carbamatos de alquil-heterociclos, seu processo de preparação, sua composição farmacêutica e seu uso. - Google Patents

compostos derivados de carbamatos de alquil-heterociclos, seu processo de preparação, sua composição farmacêutica e seu uso.

Info

Publication number: BRPI0921057A2
Authority: BR; Brazil
Prior art keywords: group; alkyl; pharmaceutical composition; preparation process; optionally substituted
Prior art date: 2008-11-14

Application number

BRPI0921057-1A

Other languages

English (en)

Inventor

Abouabdellah Ahmed

Chereze Nathalie

Fayol Aude

Saady Mourad

Vache Julien

Veronique Corinne

Yaiche Philippe

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-11-14

Filing date

2009-11-13

Publication date

2018-10-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40852115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0921057(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-11-13 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2018-10-16 Publication of BRPI0921057A2 publication Critical patent/BRPI0921057A2/pt

Links

-1 alkyl heterocycle carbamate derivatives Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
229910052731 fluorine Chemical group 0.000 abstract 2
125000001153 fluoro group Chemical group F* 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 abstract 1
FUOSTELFLYZQCW-UHFFFAOYSA-N 1,2-oxazol-3-one Chemical compound OC=1C=CON=1 FUOSTELFLYZQCW-UHFFFAOYSA-N 0.000 abstract 1
JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 abstract 1
UEFCKYIRXORTFI-UHFFFAOYSA-N 1,2-thiazolidin-3-one Chemical compound O=C1CCSN1 UEFCKYIRXORTFI-UHFFFAOYSA-N 0.000 abstract 1
IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical compound O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 abstract 1
QXDOFVVNXBGLKK-UHFFFAOYSA-N 3-Isoxazolidinone Chemical compound OC1=NOCC1 QXDOFVVNXBGLKK-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 abstract 1
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
125000001786 isothiazolyl group Chemical group 0.000 abstract 1
125000000842 isoxazolyl group Chemical group 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 abstract 1
ZVTQYRVARPYRRE-UHFFFAOYSA-N oxadiazol-4-one Chemical compound O=C1CON=N1 ZVTQYRVARPYRRE-UHFFFAOYSA-N 0.000 abstract 1
125000001715 oxadiazolyl group Chemical group 0.000 abstract 1
125000002971 oxazolyl group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 abstract 1
125000003373 pyrazinyl group Chemical group 0.000 abstract 1
JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 abstract 1
NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical compound O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 abstract 1
125000003226 pyrazolyl group Chemical group 0.000 abstract 1
125000002098 pyridazinyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000003831 tetrazolyl group Chemical group 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
XWMXMWHHTIEXRE-UHFFFAOYSA-N thiadiazole 1-oxide Chemical compound O=S1C=CN=N1 XWMXMWHHTIEXRE-UHFFFAOYSA-N 0.000 abstract 1
125000001113 thiadiazolyl group Chemical group 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1
125000004306 triazinyl group Chemical group 0.000 abstract 1
FFSJPOPLSWBGQY-UHFFFAOYSA-N triazol-4-one Chemical compound O=C1C=NN=N1 FFSJPOPLSWBGQY-UHFFFAOYSA-N 0.000 abstract 1
125000001425 triazolyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Diabetes (AREA)
Epidemiology (AREA)

BRPI0921057-1A 2008-11-14 2009-11-13 compostos derivados de carbamatos de alquil-heterociclos, seu processo de preparação, sua composição farmacêutica e seu uso. BRPI0921057A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0806371A FR2938537B1 (fr)	2008-11-14	2008-11-14	Derives de carbamates d'alkyl-heterocycles, leur preparation et leur application en therapeutique.
FR0806371		2008-11-14
PCT/FR2009/052179 WO2010055267A1 (fr)	2008-11-14	2009-11-13	Derives de carbamates d'alkyl-heterocycles, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
BRPI0921057A2 true BRPI0921057A2 (pt)	2018-10-16

Family

ID=40852115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0921057-1A BRPI0921057A2 (pt)	2008-11-14	2009-11-13	compostos derivados de carbamatos de alquil-heterociclos, seu processo de preparação, sua composição farmacêutica e seu uso.

Country Status (27)

Country	Link
US (1)	US8716289B2 (pt)
EP (1)	EP2356108B1 (pt)
JP (1)	JP5560287B2 (pt)
KR (1)	KR20110083743A (pt)
CN (1)	CN102216291B (pt)
AR (1)	AR074119A1 (pt)
AU (1)	AU2009315448B2 (pt)
BR (1)	BRPI0921057A2 (pt)
CA (1)	CA2743558C (pt)
CL (1)	CL2011001122A1 (pt)
CO (1)	CO6331472A2 (pt)
CR (1)	CR20110246A (pt)
EA (1)	EA019742B1 (pt)
EC (1)	ECSP11011040A (pt)
FR (1)	FR2938537B1 (pt)
IL (1)	IL212830A (pt)
MA (1)	MA32884B1 (pt)
MX (1)	MX2011005124A (pt)
NI (1)	NI201100095A (pt)
NZ (1)	NZ592740A (pt)
PA (1)	PA8848901A1 (pt)
PE (1)	PE20120217A1 (pt)
SV (1)	SV2011003895A (pt)
TW (1)	TWI462919B (pt)
UY (1)	UY32246A (pt)
WO (1)	WO2010055267A1 (pt)
ZA (1)	ZA201103516B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2934265B1 (fr) *	2008-07-23	2010-07-30	Sanofi Aventis	Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique
US20130150346A1 (en)	2010-01-08	2013-06-13	Quest Ventures Ltd.	Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
WO2011123719A2 (en)	2010-03-31	2011-10-06	Ironwood Pharmaceuticals, Inc.	Use of faah inhibitors for treating abdominal, visceral and pelvic pain
FR2960875B1 (fr)	2010-06-04	2012-12-28	Sanofi Aventis	Derives de carbamates d'hexafluoroisopropyle, leur preparation et leur application en therapeutique
GB201309508D0 (en) *	2013-05-28	2013-07-10	Redx Pharma Ltd	Compounds
ITMI20131180A1 (it)	2013-07-15	2015-01-16	Fond Istituto Italiano Di Tecnologia	O-alchil triazolil carbammati come inibitori di idrolasi delle ammidi degli acidi grassi (faah)
BR112017001569B1 (pt) *	2014-07-28	2020-05-05	Sumitomo Chemical Company, Limited	uso de um composto amida e método para controlar um artrópode nocivo
CN111171315B (zh) *	2020-02-25	2021-08-17	常熟理工学院	一种结晶性n-取代聚硫代氨基甲酸酯及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1558591B1 (en) *	2002-10-07	2014-05-07	The Regents of The University of California	Modulation of anxiety through blockade of anandamide hydrolysis
FR2854633B1 (fr) *	2003-05-07	2005-06-24	Sanofi Synthelabo	Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique
JP4705630B2 (ja)	2004-03-26	2011-06-22	エフ．ホフマン−ラロシュアーゲー	テトラヒドロカルバゾール及び誘導体
SE0401656D0 (sv)	2004-06-24	2004-06-24	Astrazeneca Ab	Chemical compounds
MX2007001634A (es) *	2004-08-11	2007-04-23	Kyorin Seiyaku Kk	Nuevo derivado de acido amino benzoico ciclico.
EP1871762A2 (en) *	2005-04-18	2008-01-02	Neurogen Corporation	Subtituted heteroaryl cb1 antagonists
GB0510140D0 (en)	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B2
WO2007146761A2 (en) *	2006-06-12	2007-12-21	Neurogen Corporation	Diaryl pyrimidinones and related compounds
EA020777B1 (ru)	2007-11-16	2015-01-30	Инсайт Корпорейшн	4-пиразолил-n-арилпиримидин-2-амины, 4-пиразолил-n-пиразолилпиримидин-2-амины и 4-пиразолил-n-пиридилпиримидин-2-амины в качестве ингибиторов киназ janus
FR2934265B1 (fr) *	2008-07-23	2010-07-30	Sanofi Aventis	Derives de carbamates d'alkylthiazoles, leur preparation et leur application en therapeutique

2008
- 2008-11-14 FR FR0806371A patent/FR2938537B1/fr not_active Expired - Fee Related
2009
- 2009-11-12 TW TW098138486A patent/TWI462919B/zh not_active IP Right Cessation
- 2009-11-12 PA PA20098848901A patent/PA8848901A1/es unknown
- 2009-11-13 AR ARP090104391A patent/AR074119A1/es unknown
- 2009-11-13 UY UY0001032246A patent/UY32246A/es not_active Application Discontinuation
- 2009-11-13 EP EP09768186.0A patent/EP2356108B1/fr active Active
- 2009-11-13 NZ NZ592740A patent/NZ592740A/xx not_active IP Right Cessation
- 2009-11-13 EA EA201170686A patent/EA019742B1/ru not_active IP Right Cessation
- 2009-11-13 PE PE2011001013A patent/PE20120217A1/es not_active Application Discontinuation
- 2009-11-13 BR BRPI0921057-1A patent/BRPI0921057A2/pt not_active IP Right Cessation
- 2009-11-13 AU AU2009315448A patent/AU2009315448B2/en not_active Ceased
- 2009-11-13 JP JP2011543799A patent/JP5560287B2/ja not_active Expired - Fee Related
- 2009-11-13 CN CN200980145484.6A patent/CN102216291B/zh not_active Expired - Fee Related
- 2009-11-13 KR KR1020117013456A patent/KR20110083743A/ko not_active Ceased
- 2009-11-13 CA CA2743558A patent/CA2743558C/fr not_active Expired - Fee Related
- 2009-11-13 US US13/129,235 patent/US8716289B2/en not_active Expired - Fee Related
- 2009-11-13 MX MX2011005124A patent/MX2011005124A/es active IP Right Grant
- 2009-11-13 WO PCT/FR2009/052179 patent/WO2010055267A1/fr not_active Ceased
2011
- 2011-05-05 SV SV2011003895A patent/SV2011003895A/es unknown
- 2011-05-10 CR CR20110246A patent/CR20110246A/es unknown
- 2011-05-11 NI NI201100095A patent/NI201100095A/es unknown
- 2011-05-11 EC EC2011011040A patent/ECSP11011040A/es unknown
- 2011-05-11 CO CO11057594A patent/CO6331472A2/es not_active Application Discontinuation
- 2011-05-11 IL IL212830A patent/IL212830A/en not_active IP Right Cessation
- 2011-05-13 CL CL2011001122A patent/CL2011001122A1/es unknown
- 2011-05-13 ZA ZA2011/03516A patent/ZA201103516B/en unknown
- 2011-06-08 MA MA33921A patent/MA32884B1/fr unknown

Also Published As

Publication number	Publication date
MX2011005124A (es)	2011-05-30
ECSP11011040A (es)	2011-06-30
NI201100095A (es)	2011-12-14
CA2743558A1 (fr)	2010-05-20
PE20120217A1 (es)	2012-03-12
IL212830A (en)	2014-11-30
CR20110246A (es)	2012-06-15
UY32246A (es)	2010-06-30
JP2012508785A (ja)	2012-04-12
CL2011001122A1 (es)	2011-09-16
IL212830A0 (en)	2011-07-31
FR2938537A1 (fr)	2010-05-21
EP2356108B1 (fr)	2014-10-15
ZA201103516B (en)	2012-07-25
KR20110083743A (ko)	2011-07-20
TWI462919B (zh)	2014-12-01
FR2938537B1 (fr)	2012-10-26
US8716289B2 (en)	2014-05-06
CN102216291B (zh)	2016-08-03
SV2011003895A (es)	2011-08-15
CN102216291A (zh)	2011-10-12
CO6331472A2 (es)	2011-10-20
EP2356108A1 (fr)	2011-08-17
PA8848901A1 (es)	2010-06-28
WO2010055267A1 (fr)	2010-05-20
AU2009315448B2 (en)	2015-07-16
CA2743558C (fr)	2017-02-14
AR074119A1 (es)	2010-12-22
NZ592740A (en)	2013-03-28
US20120015950A1 (en)	2012-01-19
EA019742B1 (ru)	2014-05-30
AU2009315448A1 (en)	2010-05-20
TW201026692A (en)	2010-07-16
EA201170686A1 (ru)	2011-12-30
JP5560287B2 (ja)	2014-07-23
MA32884B1 (fr)	2011-12-01

Legal Events

Date	Code	Title	Description
2018-10-30	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-10-30	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 9A ANUIDADE.
2019-03-19	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
NI201100095A (es)	2011-12-14	Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica.
HRP20201745T1 (hr)	2020-12-25	Paraziticidni pripravci koji sadrže djelatno sredstvo izoksazolina, postupak za njih i njihove uporabe
RU2436780C2 (ru)	2011-12-20	Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
Bekhit et al.	2010	Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents
HRP20180212T1 (hr)	2018-03-09	Derivati 1-fenil-2-piridinilalkil-alkohola kao inhibitori fosfodiesteraze
RU2006118326A (ru)	2007-12-10	Производное циклического амина, содержащее гетероарильный цикл
WO2005037781A3 (fr)	2005-07-14	Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
NO933198L (no)	1994-03-11	Forbindelser anvendelige som hypoglycemiske midler og for behandling av Alzheimer's sykdom
CA2684105A1 (en)	2008-11-13	Pyridine derivatives
NZ590285A (en)	2012-10-26	Heteroaryl derivatives as dgat1 inhibitors
HK1079794A1 (zh)	2006-04-13	用作抗菌药物的恶唑烷酮和/或异恶唑啉衍生物
RU2408589C2 (ru)	2011-01-10	Соединения и композиции в качестве модуляторов ppar-рецепторов, активируемых пролифератором пероксисом
BRPI0707491B8 (pt)	2021-05-25	compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas
HRP20090383T1 (en)	2009-08-31	Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
RU2009117705A (ru)	2010-11-20	Производные 2-аминокарбонилпиридина
EP1702917A4 (en)	2009-06-03	AMID DERIVATIVE AND MEDICINE
CA2744756A1 (en)	2010-06-24	Monocarbams and their use as antibacterial agent
RU2006125446A (ru)	2008-01-27	Производные n-замещенного n-сульфониламиноциклопропана и их фармацевтическое применение
HRP20191554T1 (hr)	2019-11-29	Derivat azol benzena
CA2494832A1 (en)	2004-02-19	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
JP2012512863A5 (pt)	2012-12-06
RU2015101102A (ru)	2016-08-10	Гетероароматическое метильное производное циклического амина
PE20120732A1 (es)	2012-06-20	Agonistas del receptor de esfingosina-1-fosfato
SE0201937D0 (sv)	2002-06-20	Therapeutic agents
WO2010095024A3 (en)	2010-12-02	An improved process for the preparation of celecoxib and purification process